Carman Alenson
Comptroller/Controller/Auditor bei PRIME MEDICINE, INC.
Vermögen: - $ am 30.04.2024
Profil
Carman Alenson is currently working as the Principal Accounting Officer at Prime Medicine, Inc. Ms. Alenson previously worked as the Executive Director-Accounting & Controller at AMAG Pharmaceuticals, Inc. from 2015 to 2016 and as the CAO, Vice President-Accounting, Treasury & Tax at Agios Pharmaceuticals, Inc. from 2016 to 2021.
Ms. Alenson obtained an undergraduate degree and an MBA from Boston University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PRIME MEDICINE, INC.
-.--% | 21.02.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Carman Alenson
| Unternehmen | Position | Beginn |
|---|---|---|
| PRIME MEDICINE, INC. | Comptroller/Controller/Auditor | 01.08.2021 |
Ehemalige bekannte Positionen von Carman Alenson
| Unternehmen | Position | Ende |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 30.07.2021 |
| AMAG PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01.10.2016 |
Ausbildung von Carman Alenson
| Boston University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| PRIME MEDICINE, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
